Dougald M Monroe
University of North Carolina at Chapel Hill
H-index: 62
North America-United States
Top articles of Dougald M Monroe
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Emicizumab promotes factor Xa generation on endothelial cells | Journal of Thrombosis and Haemostasis | Ammon M Fager Patrick Ellsworth Nigel S Key Dougald M Monroe Maureane Hoffman | 2024/3/8 |
Stopping the bleed when platelets don’t stick | Nature Cardiovascular Research | Ammon M Fager Dougald M Monroe | 2024/2/8 |
Hypertonicity and/or Acidosis Induce Marked Rheological Changes Under Hypoxic Conditions in Sickle Trait Red Blood Cells | Blood | Patrick Ellsworth Izabela Pawlinski Rachel Sielaty Anton Ilich Chatphatai Moonla | 2023/11/28 |
Evaluation of four commercial ELISAs to measure tissue factor in human plasma | Research and Practice in Thrombosis and Haemostasis | Ana TA Sachetto Sierra J Archibald Ravi Bhatia Dougald Monroe Yohei Hisada | 2023/3/1 |
Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency | Journal of Thrombosis and Haemostasis | Stéphanie E Reitsma Lori A Holle Emma G Bouck Dougald M Monroe Alan E Mast | 2023/3/1 |
Mathematical modeling to identify clotting factor combinations that modify thrombin generation in hemophilia | Blood | Michael Stobb Dougald Monroe Keith B Neeves Suzanne Sindi Aaron Fogelson | 2022/11/15 |
Low normal factor V enhances thrombin generation in hemophilia A by a substrate competition mechanism with factor Xa | bioRxiv | Dougald M Monroe Christine Baird Julie A Peterson Alan E Mast Marilyn Manco-Johnson | 2022/6/27 |
Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors | Nature Communications | Cho Yeow Koh Norrapat Shih Christina YC Yip Aaron Wei Liang Li Weiming Chen | 2021/11/25 |
Emizicumab Promotes Factor Xa Generation on Activated Endothelium in a Blood Cell-Independent Manner | Blood | Patrick Ellsworth Dougald Monroe Maureane Hoffman Nigel S Key | 2021/11/23 |
The art and science of building a computational model to understand hemostasis | Karin Leiderman Suzanne S Sindi Dougald M Monroe Aaron L Fogelson Keith B Neeves | 2021/3 | |
Computationally driven discovery in coagulation | Kathryn G Link Michael T Stobb Dougald M Monroe Aaron L Fogelson Keith B Neeves | 2021/1 | |
Synergistic effect of bypassing agents and sequence identical analogue of emicizumab and fibrin clot structure in the in vitro model of hemophilia A | TH Open | Yanan Zong Aleksandra Antovic Nida Mahmoud Hourani Soutari Jovan Antovic Iva Pruner | 2020/4 |
VWF (von Willebrand Factor) is not required for red blood cell retention in clots in mice | Arteriosclerosis, thrombosis, and vascular biology | Lori A Holle Dougald M Monroe Alisa S Wolberg | 2020/8 |
Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways | Blood, The Journal of the American Society of Hematology | Denis F Noubouossie Michael W Henderson Micah Mooberry Anton Ilich Patrick Ellsworth | 2020/3/5 |
Protease: serpin complexes to assess contact system and intrinsic pathway activation | Research and Practice in Thrombosis and Haemostasis | Michael W Henderson Denis F Noubouossie Anton Ilich Kathy J Wilson Rafal Pawlinski | 2020/7/1 |
Clot structure and implications for bleeding and thrombosis | Emily Mihalko Ashley C Brown | 2020/2 | |
EPCR knockout: inflaming the discussion | Blood, The Journal of the American Society of Hematology | Dougald Monroe Maureane Hoffman | 2020/6/18 |
Understanding the effects of NOAC combined with antiplatelet therapy on clot kinetics | Thrombosis and haemostasis | Diana A Gorog | 2020/1 |
Mouse models of hemostasis | Bassem M Mohammed Dougald M Monroe David Gailani | 2020/5/18 | |
In Hemophilia Α Plasma Treated with Emicizumab, Factor IX Activation By Factor VIIa Drives Thrombin Generation | Blood | Dougald Monroe Mirella Ezban Maureane Hoffman | 2020/11/5 |
